Oruka Therapeutics (ORKA) Selling, General & Administrative (2010 - 2024)

Oruka Therapeutics (ORKA) Selling, General & Administrative (2010 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -10.08 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 555.10 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.47 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 17.02 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.13 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 101.25 Mn
10 Oruka Therapeutics 36.09 Mn -795.06 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 2.99 Mn
Mar 31, 2024 2.32 Mn
Dec 31, 2023 1.54 Mn
Sep 30, 2023 1.62 Mn
Jun 30, 2023 1.72 Mn
Mar 31, 2023 1.41 Mn
Dec 31, 2022 1.49 Mn
Sep 30, 2022 1.53 Mn
Jun 30, 2022 1.73 Mn
Mar 31, 2022 1.10 Mn
Dec 31, 2021 1.74 Mn
Sep 30, 2021 1.28 Mn
Jun 30, 2021 1.26 Mn
Mar 31, 2021 1.23 Mn
Dec 31, 2020 1.92 Mn
Sep 30, 2020 939,000.00
Jun 30, 2020 938,000.00
Mar 31, 2020 975,000.00
Dec 31, 2019 894,000.00
Sep 30, 2019 900,000.00